Search results
FDA Panel to Consider Updating COVID-19 Jabs for New Virus Strains
Zacks· 5 days agoShares of COVID-19 vaccine developers rose on Monday after the FDA issued briefing documents for its Vaccines and ...
Moderna's RSV Vaccine Approved by FDA
Medscape· 6 days agoFor the first time, an mRNA vaccine has been approved for an indication other than COVID-19. The vaccine will join ...
Moderna Files FDA Application for the JN.1 Targeting COVID-19 Vaccine
The Kansas City Star· 2 days agoManufacturing is underway and doses of Moderna’s Spikevax 2024-2025 formula will be ready to ship as early as August, pending regulatory approval
FDA Advisers Recommend Omicron-Focused COVID Boosters for Fall
Homenewshere.com· 3 days agoFDA advisers recommended that the new COVID-19 boosters for fall target the Omicron variant, which...
Is Moderna Stock A Buy After Its Second-Ever Product Snags FDA Approval?
Investor's Business Daily· 2 days agoModerna also recently gained FDA approval for its second product, the RSV shot. In older adults, the...
Adults 60+ Will Have 3 RSV Vaccines to Choose From This Year
Verywell Health via Yahoo News· 4 days agoThe FDA approved mRESVIA based on data from a clinical trial that included more than 35,000 adults...
Moderna (MRNA) Secures FDA Nod for mRNA-Based RSV Vaccine
Zacks· 6 days agoThe RSV vaccine is Moderna???s (MRNA) second FDA-approved product. Once the vaccine secures the CDC's recommendation ...
mRESVIA’s FDA approval paves the way for mRNA vaccines across multiple indications
Clinical Trials Arena via Yahoo Finance· 3 days agoModerna’s respiratory syncytial virus (RSV) vaccine mRESVIA has received US Food and Drug...
How Moderna’s newly approved RSV vaccine could impact 2024 revenue - Boston Business Journal
The Business Journals· 6 days ago(Nasdaq: MRNA) notched its second-ever FDA product approval, this time for its mRNA vaccine for...
The new technology inside COVID-19 vaccines— mRNA
KRGV Rio Grande Valley· 7 days agoWhen you think of vaccines, you may think about traditional vaccines with weak or inactive parts of a virus to trigger an immune response. Today...